Healthcare & Life Sciences Transactions
News & Insights for Public Companies
- Kirkland Advises Eli Lilly on Acquisition of Kelonia Therapeutics
- Kirkland Advises Eli Lilly on Agreement to Acquire Centessa Pharmaceuticals for up to $7.8 Billion
- Kirkland Advises Danaher on $9.9 Billion Acquisition of Masimo
- Kirkland Advises Amicus Therapeutics on $4.8 Billion Sale to BioMarin
- Kirkland Advises Kestra Medical Technologies, Ltd. on Upsized Primary Public Offering of Common Shares
- Kirkland Advises Bristol Myers Squibb on €5 Billion Senior Notes Offering and $7.5 Billion Tender Offer for Outstanding Notes
- Kirkland Advises Kimberly-Clark on $48.7 Billion Acquisition of Kenvue
- Kirkland Advises Akero Therapeutics on $5.2 Billion Sale to Novo Nordisk
- Kirkland Advises Owens & Minor on Sale of Products & Healthcare Services Segment